Has your doctor told you that you have diabetes, are overweight or have fatty liver?
You may be at risk for a liver disease called NASH, and may be eligible for a study of an investigational treatment for this disease.
NASH (nonalcoholic steatohepatitis) is caused by a buildup of fat in the liver. If it progresses, it can lead to liver damage or cirrhosis.
A research study is being conducted to evaluate the safety and effects on liver fat of two oral investigational medications when used together, or when used singularly, compared to placebo (an inactive substance), for the treatment of NASH. You may be eligible to join this study if you are:
- Male, or female of non-childbearing potential, between the ages of 18 and 70, and
- Willing to follow a plan of scheduled study visits, lab tests and other study procedures for the duration of the study; up to 19 weeks.
For eligible study participants, all study medication, taken in tablet form, or placebo and study doctor visits will be provided at no cost to you during the study period. Participation in the study is voluntary and you may withdraw at any time.
To learn more, call
East Wichita location at 316-689-6652
Please fill out your information below and a Heartland Research specialist will contact you with more information for this study.
The information you provide is entered in our secure, password protected database. The provided information will only be used to contact you to tell you more about the study. You have the choice to have your information saved or removed from our records. If you elect to have contact information saved within our database, it will remain indefinitely. To be removed please call a Heartland Research specialist at 316-689-6626 or email email@example.com.